Recent studies have found increased levels of Nfl in COVID-19 patients [20–22] but the effects of concomitant systemic inflammatory disease such as cardiac disease or diabetes on neuronal injury as measured by NfL in COVID-19 patients has not been previously reported. Here, NEFL is linked to heart disorder.